新田ゼラチン(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 化学 | 4977/E26061 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/08/28 | 日証協 | 124,996株 | -9.75% | 6,200株 | -84.34% | 263,465株 | -5.39% | 5,300株 | -66.03% |
2020/08/21 | 日証協 | 138,496株 | -7.91% | 39,600株 | +538.71% | 278,465株 | -5.08% | 15,600株 | +92.59% |
2020/08/14 | 日証協 | 150,396株 | +4.3% | 6,200株 | -56.65% | 293,382株 | +1.19% | 8,100株 | -42.66% |
2020/08/07 | 日証協 | 144,196株 | -8.44% | 14,301株 | -75.55% | 289,933株 | -2.68% | 14,126株 | +48.43% |
2020/07/22 | 日証協 | 161,018株 | +2.09% | 8,400株 | -57.36% | 298,016株 | +2.06% | 10,200株 | -46.65% |
2020/07/17 | 日証協 | 157,718株 | -1.7% | 19,700株 | -85.65% | 292,015株 | -2.86% | 19,120株 | -33.38% |
2020/07/10 | 日証協 | 160,446株 | +5.35% | 137,300株 | +45.14% | 300,600株 | -1.01% | 28,700株 | -76.2% |
2020/07/03 | 日証協 | 152,292株 | +49.32% | 94,600株 | +119.39% | 303,674株 | +26.37% | 120,600株 | +300.66% |
2020/06/26 | 日証協 | 101,992株 | +9.33% | 43,120株 | +77.3% | 240,297株 | +1.78% | 30,100株 | +34.95% |
2020/06/12 | 日証協 | 94,792株 | -5.86% | 19,920株 | +20% | 235,696株 | -2.76% | 10,201株 | -54.47% |
2020/06/05 | 日証協 | 100,692株 | +1.41% | 16,600株 | +140.58% | 242,396株 | -4.42% | 22,405株 | -1.73% |
2020/05/29 | 日証協 | 99,292株 | +5.3% | 6,900株 | -2.82% | 253,596株 | -0.84% | 22,800株 | -14.29% |
2020/05/22 | 日証協 | 94,292株 | -0.84% | 7,100株 | -83.69% | 255,738株 | -0.44% | 26,600株 | +146.41% |
2020/05/15 | 日証協 | 95,092株 | -11.45% | 43,540株 | +1879.09% | 256,866株 | -3.02% | 10,795株 | +96.27% |
2020/05/08 | 日証協 | 107,387株 | -3.94% | 2,200株 | -15.38% | 264,866株 | -1.08% | 5,500株 | -61.81% |
2020/05/01 | 日証協 | 111,787株 | -12.04% | 2,600株 | +18.18% | 267,766株 | -9.65% | 14,400株 | +53.9% |
2020/04/24 | 日証協 | 127,087株 | -9.91% | 2,200株 | -73.17% | 296,366株 | -0.9% | 9,357株 | -66.13% |
2020/04/17 | 日証協 | 141,072株 | -9.1% | 8,200株 | -80.99% | 299,066株 | -27.76% | 27,628株 | +36.77% |
2020/04/10 | 日証協 | 155,203株 | -10.19% | 43,135株 | -12.72% | 413,992株 | +0.05% | 20,200株 | -81.89% |
※株式分割は考慮していませんのでご注意ください。
Page Top